title: [The role of and suitability of the occult fecal blood test in a preventive program for colorectal carcinoma].
abstract: There are no final attitudes towards the necessity of the colorectal carcinoma screening in the population. The aim of this examination was to assess the motivation, applicability, sensibility and value of the occult faecal blood tests as the screening method in the colorectal carcinoma detection, as well as the analysis of the costs and the possibilities of testing within the regular health service. The testing of the occult faecal blood was offered to a random sample of 11.431 subjects. The tests were returned by 7.592 (81.9%) of the high-risk and by 1.690 (77.8%) of the control group testees. In the high-risk group (over 40 years of age) the positive test of the occult faecal blood was found in 1.09% of the examined patients and the colon carcinoma was established in 13 testees with the positive test (19.66%) or in 0.17% of the cases. The total costs per patient with a detected carcinoma were Din. 349.246. - what is 24.4% less than the price of a palliative operation. Colon adenoma was established in 16 testees of the high-risk group (0.21%). Colon adenoma and carcinoma were established in 34.94% of the testees with positive tests. Radical surgeries were made in 8 out of 10 operated testees. In the control group (20-40 years of age) two adenomas were established and no malignant disease. The test sensitivity was evaluated based on the colon carcinoma detection and it was 72.2% in Hemoccult-negative subjects up to two years after the testing.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.forename: Z
authors.initials: Z
authors.lastname: Ebling
authors.forename: N
authors.initials: N
authors.lastname: Hadzić
mesh_terms: D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000191:economics / Q000517:prevention & control*; D006801:Humans; D008403:Mass Screening / Q000191:economics; D009780:Occult Blood; D015022:Yugoslavia
vernacular_title: Uloga i prikladnost testiranja okultnoga fekalnog krvarenja u programu zastite od kolorektalnog karcinoma.